JAWED SIDDIQUI: Open Payments
NPI 1699705293 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 25 payments from 9 companies in 2025. Trend: 2023 $461 · 2024 $25 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $215 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| PROTEGA PHARMACEUTIALS INC | 2 | $44 |
| Itamar Medical Inc | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Auvelity, LEQVIO, ROXYBOND, Belbuca, WatchPATONE, XTAMPZA, AUSTEDO XR, TRINTELLIX.
Industry payments across MO — which companies pay providers there.
